The Recall Desk
HighFDA (Drugs)·D-881-2013·Announced 2013-08-21

Verapamil Injection Is Recalled Over Sterility Assurance Concerns

FDA is recalling Verapamil Injection compounded by Pallimed Solutions Pharmacy because inspectional findings raised concerns about quality-control procedures and sterility assurance. The recall covers all lots within expiry distributed nationwide.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The source identifies an FDA Class II recall involving a sterility-assurance risk, but it does not report hospitalization or other injury. This meets the rubric's High criterion for a risk-of-harm product where injury has not yet been reported.

Plain-English summary

FDA is recalling Verapamil Injection compounded by Pallimed Solutions Pharmacy in Woburn, Massachusetts. The recall covers all lots within expiry distributed nationwide.

FDA inspectional findings raised concerns about quality-control procedures that impacted sterility assurance. The source does not provide specific consumer instructions.

The recalled product

Product
Verapamil Injection, compounded by Pallimed Solutions Pharmacy, Woburn, MA
Manufacturer
Pallimed Solutions

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All lots within expiry

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 25 recalled by Pallimed Solutions under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 25 products in this recall →